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Abstract 
In this article the problems of the prevalence of esophageal cancer and the spatial distribution of mortality rates 
from this disease are considered using as examples the NUTS 2 regions in six countries of Central and Eastern 
Europe (Austria, Germany, the Czech Republic, Poland, Slovakia and Hungary). The rates of mortality from 
esophageal cancer are analyzed by statistical methods and by spatial econometrics. A study is carried out of the 
features of the spatial distribution of the rates of mortality from esophageal cancer. It allows us to determine more 
and less epidemiologically affected regions and to carry out more detailed studies on the link between the mortality 
rates from esophageal cancer and various factors, such as the environmental situation, socio-demographic 
characteristics of the population, culture and nature of nutrition, the general health status of the population, the 
availability of resources and the level of healthcare in the region. By means of the multifactor regression model we 
forecast the rates of mortality from esophageal cancer, taking into account characteristics of the countries, the 
dynamics of the number of patients with diseases of the esophagus and the general time trend. 
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1. Introduction 
Esophageal cancer ranks sixth in the world among the main causes of death connected with malignant tumors. 
More than 450 000 people worldwide have this diagnosis and the occurrence of this disease is increasing rapidly 
(Cancer Trends, 2011). Standardized rates of the frequency of incidence of esophageal cancer and the rates of 
mortality from this cause differ significantly by countries  and regions. High rates of incidence of esophageal cancer 
are registered in southern and eastern Africa, the USA, Singapore and other countries forming the so-called “Asian 
belt” (Turkey, the northeast of Iran, Kazakhstan, the northern and central regions of China). In the EU countries the 
highest standardized rates of incidence of esophageal cancer are registered in Great Britain, Ireland, the Netherlands, 
Belgium, Denmark, France, Hungary and Lithuania (Kollarova et  al, 2007, Pennathur et al, 2013).  
Two histological types of esophageal cancer – squamous carcinoma and adenocarcinoma – are predominant, and 
there are notable trends of prevalence of one type of carcinoma over another in different countries and continents, 
arguing different aetiology of incidence of these types of carcinoma and different habitude of certain populations 
and races to these types of carcinoma (Lepage et al, 2008, Pennathur et al, 2013). Other types of esophageal cancer 
(melanoma, leyosarcoma etc.) occur quite rarely.  
Squamous esophageal carcinoma is the most prevalent carcinoma of the esophagus worldwide and it is the most 
frequent in some Asian countries, in Kazakhstan, in northern and southern Africa, and in northern and central China. 
In these countries the rate of incidence of esophageal carcinoma is more than 100 cases per 100 thousand 
population. In the economically developed countries of Europe, in the USA, in Australia and Singapore, with a so-
called “Western lifestyle,” adenocarcinoma of the esophagus is more prevalent, or else both types of esophageal 
carcinoma occur with equal frequency. The rates of incidence of esophageal cancer differ by age and gender groups. 
The risk of occurrence of this disease increases with age, and esophageal cancer occurs more frequently in males 
than in females (Ribeiro, 1996, Castellsague and Lagergren, 1999, Wu, 2001,  Mayne, 2002,  Lindblad, 2005, Yao, 
2006 ). 
Among the main reasons giving rise to a risk of esophageal cancer, the following are noted: smoking and overuse 
of alcohol; obesity; overconsumption of smoked and fried red meat products, preserved products, marinated or spicy 
food; insufficient consumption of fruits and vegetables; use of too hot food and drinks; intoxication with pesticides 
or nitrates; use of corns, affected with mold fungi; environmental pollution; work with petroleum products.   
Factors contributing to the growth of squamous esophageal carcinoma are: achalasia, mutations of enzymes 
assisting in the metabolism of alcohol; intoxication with caustic soda; irradiation of the chest; non-epidermolytic 
palmoplantar keratoderma. Among the factors affecting the growth of esophageal adenocarcinoma, the following are 
noted: symptomatic gastro-esophageal reflux; Barret’s esophagus; irradiation of the chest; the use of drugs assisting 
in the relaxation of the lower esophageal sphincter; hereditary factors (Castellsague and Lagergren, 1999, Wu, 2001, 
Mayne, 2002,  Polednak, 2003,  Reid, 2010).  
Research carried out in different countries has indicated that the prognosis of the course of esophageal cancer is 
unfavorable, because the disease is predominantly diagnosed in the later stages (Polednak, 2003, Pennathur, 2008, 
2013). Even if cancer is diagnosed in the early stages and a surgical operation is possible, the survival rate is much 
less than in the case of other types of cancer. Thus, the survival potential of patients with esophageal cancer in 
economically developed countries with a high standard of living and high consumption of healthcare is 15% to 25% 
over a 5-year time horizon, while in countries with transitional economies and a low standard of living and 
healthcare, this probability is 5% to 10%, and sometimes even less (Pennathur, 2008, 2009, 2013). Despite certain 
progress and positive results in the detection and treatment of esophageal cancer, mortality rates remain high in the 
USA and in the EU ( Polednak, 2003, Lepage, 2008,  Pennathur, 2013). 
A number of epidemiological studies related to the analysis of the prevalence of esophageal cancer in the Czech 
Republic and Hungary are presented in the studies of H. Kollarova, L. Mahova, L. Gersheni, Sh .Tulassaya et al. 
(Dušek, 2005, Kollarova, 2007). At the same time, there is scientific interest in a study of the epidemiological 
features of esophageal cancer in the countries of Central and Eastern Europe (CEE), which makes a comparative 
analysis of morbidity and mortality rates in different CEE countries taking into account the prevailing trends and 
which constructs predictions based on the application of mathematical and statistical methods and models.  
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2 Purpose, materials and methods of the study 
 
The following purposes were set in the study: to investigate the rates of incidence of the esophageal cancer and the 
corresponding rates of mortality using the example of six CEE countries (Austria, Germany, the Czech Republic, 
Poland, Slovakia and Hungary); to explore the features of the spatial distribution of mortality from esophageal 
cancer for the regions of these countries; and to obtain predicted values of mortality, based on existing trends and 
characteristics of these countries. The materials on which the research is based are: Eurostat data, containing the 
rates of morbidity and mortality from different causes in the EU countries and in the regions of NUTS2; and results 
arising from the analysis of various reports of scientists engaged in problems of oncologic diseases. The methods of 
analysis of time series, methods of spatial econometrics and statistics were used for the study, presented here.  
Statistica and R were used for information processing and the required calculations.  
 
3. The results of statistical and econometrical study 
 
The problem of the increasing growth rate of the spread of oncologic diseases is one of the most important for 
national healthcare systems in the countries of Central and Eastern Europe (CEE). The rates of mortality and 
morbidity caused by esophageal cancer for six countries of Central and Eastern European (Austria, Germany, the 
Czech Republic, Poland, Slovakia and Hungary) are analysed in our study. The selection of these countries is 
interesting from the standpoint of studying the epidemiological characteristics of the extension of esophageal cancer 
using the methods of spatial statistics (Kopczewska, 2006), as well as a comparative analysis of the situation in 
countries with different levels of socio-economic development and healthcare. The results of mathematical and 
statistical analysis of the distribution of mortality from esophageal cancer by NUTS2 regions of six CEE countries 
from 2001 to 2010 were carried out.  
As followed from the statistical analysis, the average rate of mortality from esophageal cancer is 4.71 per 100 
thousand population for the entire sample, containing data on 84 NUTS2 regions of six CEE countries in 2001, but 
there is quite a high (about 27.61%) value of the coefficient of variation, indicating heterogeneity of rates across 
countries and regions. Thus, for the data of the year 2001, the minimum mortality rate from esophageal cancer was 
2.1 per 100 thousand population in the Czech Republic (Prague region), and the maximum rate was 7.7 per 100 
thousand population in Hungary (northern Hungary region). The coefficients of variation of mortality from 
esophageal cancer differ significantly across countries. Thus, in 2001, the lowest rate of the coefficient of variation 
in mortality from esophageal cancer was in Hungary (14.721%), and the highest one in Austria (37.77%). 
In 2001 in Austria, the lowest rate of mortality from esophageal cancer was registered in the region of Upper 
Austria (2.5 per 100 thousand population) and the highest in the region of Burgenland (7.5 per 100 thousand 
population).  
In the Czech Republic in 2001 the lowest rate of mortality from esophageal cancer was observed in the region of 
Prague (2.1 per 100 thousand population) and the highest in the region of Central Moravia (4.6 per 100 thousand 
population).  
In Germany in 2001 the lowest rate of mortality from esophageal cancer was observed in Lower Bavaria (4.2 per 
100 thousand population), and the highest in Chemnitz (7.2 per 100 thousand population).  
In Hungary in 2001 the lowest rate of mortality from esophageal cancer was in the region of Southern Alföld 
(Southern Great Plain) (5.7 per 100 thousand population), and the highest in Northern Hungary (7.7 per 100 
thousand population).  
In Poland in 2001, the lowest rate of mortality from esophageal cancer was in the Subcarpathian Voivodeship (2.2 
per 100 thousand population), and the highest value of this index was noted in Opole Voivodeship (5.1 per 100 
thousand population).  
In Slovakia in 2001, the lowest rates of mortality from esophageal cancer were observed in the Bratislava region 
(3.7 per 100 thousand population), and the highest one – in the region of Western Slovakia (6.4 per 100 thousand 
population). 
In 2010 the average rate of mortality from esophageal cancer was 5.217 per 100 thousand population, 
demonstrating a growth in the average rate. In addition, the value of the coefficient of variation of mortality from 
esophageal cancer for the entire sample increased to 30%.  At the same time, a decrease in the values of the 
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coefficients of variation was observed for individual countries. Thus, the lowest values of the coefficients of 
variation in mortality from esophageal cancer were observed in the Czech Republic (12.242%) and Hungary 
(16.418%), while the highest one – in Austria (26.43%). In 2010 the lowest rate of mortality from esophageal cancer 
was noted in the Subcarpathian Voivodeship in Poland and was 2.0 per 100 thousand population, and the highest 
(10.1) was registered in the region of Trier (Germany).   
In 2010 in Austria the lowest mortality rate from esophageal cancer (3.0 per 100 thousand population) was 
observed in several regions (Tyrol, Salzburg, Carinthia), and the highest was observed in Burgenland (6.0 per 100 
thousand population).  
In the Czech Republic in 2010 the lowest mortality rate from esophageal cancer was registered in Prague (3.8 per 
100 thousand population) and the highest (5.4 per 100 thousand population) was observed in the region of Central 
Moravia.  
In Germany in 2010 the lowest rate of mortality from esophageal cancer was in Lower Bavaria (3.7 per 100 
thousand population), and the highest in Trier (10.1 per 100 thousand population).  
In Hungary in 2010 the lowest rate of mortality from esophageal cancer was observed in the region of West 
Dunantul (5.1 per 100 thousand population), and the highest in Northern Hungary (7.7 per 100 thousand 
population).  
 In Poland in 2010 the lowest rate of mortality from esophageal cancer was registered in Subcarpathian 
Voivodeship (2.0 per 100 thousand population), and the highest in Podlachian Voivodeship (4.6 per 100 thousand 
population).  
In Slovakia in 2010 the lowest rate of mortality from esophageal cancer was in Eastern Slovakia (3.9 per 100 
thousand population), and the highest in Central Slovakia (6.1 per 100 thousand population).   
The high homogeneity of the data and the reduction of variations in the values between regions can be explained 
by the pursuit of a committed policy in the area of cancer prevention carried out at the regional level, particularly in 
disadvantaged areas. For example, in 2001 the mean rate of mortality from esophageal cancer was markedly higher 
in Hungary, but in 2010 this striking difference against the background of the other countries is absent.  
Using spatial econometrics tools in R, the maps were constructed for the analysis of spatial features of the 
distribution of the rates of mortality from esophageal cancer; in this case the NUTS2 regions of the six CEE 
countries were split into four groups according to their values.  
The first group includes regions where the rates of mortality from esophageal cancer do not exceed the lower 
quartile; the second group includes regions where the rates are in the range from the lower quartile to the median; 
the third group includes regions where the rates are greater than the median, but less than the upper quartile; the 
fourth group includes regions where the rates are greater than the upper quartile.  
Based on a visual analysis of the maps it is evident that the most disadvantaged areas, with quite high mortality 
rates from esophageal cancer, are represented by clusters of regions in northwestern Germany and in Hungary. To 
justify the existence of a nonrandom distribution of groups of regions, characterized by different rates of mortality 
from esophageal cancer, the values of the coefficients of spatial correlation known as Moran’s I and Geary’s C were 
calculated.  From the statistical significance of the Moran and Geary coefficients, as calculated by the authors, a 
moderate positive spatial autocorrelation is observed for the data of 2001 and of 2010. That is, based on the spatial 
analysis of the distribution of the rates of mortality from esophageal cancer, we can conclude that, in general, 
regions with higher mortality rates from esophageal carcinoma are surrounded by similar regions, i.e., regions with 
relatively high rates, and, vice versa, regions with lower rates of mortality from esophageal cancer are surrounded by 
regions with low values of these rates.  
The methods of spatial statistics allow us to analyze various local clusters of regions and to explore the spatial 
régimes where the qualitative change from one group of regions to another takes place.  There are four types of 
spatial régimes: “HH” – regions with quite high rates, surrounded by regions with high rates; “HL” – regions with 
high rates, surrounded by regions with low rates; “LL” – regions with low rates, surrounded by regions with 
relatively low rates; “LH” – regions with low rates, surrounded by regions with high rates (see Kopczewska, 2006). 
Fig. 1 shows the spatial régimes characterizing the features of distribution of mortality rates from esophageal cancer 
in the regions of CEE countries. 
 
 












Fig. 1. Spatial regimes of distribution of mortality rates from esophageal cancer per 100 thousand population for the 
NUTS2 regions of CEE countries in 2001 and 2010 
Source: Eurostat data, processed by N. Dubrovina in R. 
 
Based on an analysis of maps for these régimes built in R, we can see that the northwestern and central regions of 
Germany, and certain regions of Hungary, are characterized as régimes of “HH” type, i.e. where regions with quite 
high rates are surrounded by regions with similarly high rates. At the same time, “LL” régimes, i.e. where regions 
with low rates are surrounded by regions with relatively low rates, are characteristic for the majority of regions in 
Poland, the Czech Republic and Austria. Transient regimes occur in certain central and southern regions of Germany 
or in frontier regions of other countries.   
To investigate the dynamics of rates of mortality from esophageal cancer in CEE countries, it is advisable to 
analyze trend models.  
A linear trend equation  has the form (1): 
 
                                                                     taay kkkt  ,1,ˆ ,                                                          (1) 
 
where the kty ,ˆ  are the forecast values of rates of mortality from esophageal cancer (per 100 thousand) in year t  for 
country k, ka  and ka ,1  are estimates of the model parameters of a linear trend for the rates of mortality from 
esophageal cancer in the country k , and t  is the time factor.  
Data on rates of mortality from esophageal cancer (per 100 thousand population) in CEE countries during the 
period of 2000–2010 were used for the construction of models of linear trends. 
The estimation of the ka  parameter can be interpreted as an initial level of the rate of mortality from esophageal 
cancer in the moment of time t = 0 (for the year 2000) for country k , and ka ,1  is an annual rate of change of the 
rate of mortality from esophageal cancer in country k . The variable t  takes the value 1 for the year 2001, 2 for the 
year 2002 etc.  The estimates ka  and ka ,1  of the unknown parameters for the linear trend model are found with the 
help of least squares method.  
As seen from the results of trend analysis, the trends in the rates of mortality from esophageal cancer in Austria, 
the Czech Republic, Germany and Hungary are described quite well by linear models, as argued by sufficiently high 
coefficients of correlation. 
This trend is observed most clearly for Germany, where the coefficient of correlation, 0.955, is close to 1.  
Different estimates of the ka  parameter are observed for different countries, revealing the presence of initial 
differences between countries. The estimates of ka ,1  are positive for Austria, the Czech Republic and Germany, 
indicating an annual growth of the rates of mortality from esophageal cancer, while the estimate of ka  is negative in 
Hungary, indicating that the rates of mortality from esophageal cancer are tending to decrease. 
No linear trends were observed in the rates of mortality from esophageal cancer in Poland and Slovakia during the 
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period 2000–2010, as indicated by the fact that the estimates of the ka ,1  and the relevant values of the coefficients 
of correlation are close to 0.   
The analysis of interdependencies of the trends in the rates of mortality from esophageal cancer, carried out on the 
basis of matrices of correlations between the trends in CEE countries, demonstrated that the trends in these rates are 
the most interconnected in Germany and Austria (coefficient of pair correlation is 0.684), and also in the Czech 
Republic and Germany (coefficient of pair correlation is 0.517).     
The trends in the rates of mortality from esophageal cancer have a significant inverse relationship in Austria, the 
Czech Republic and Germany in comparison with the trend in Hungary, as indicated by the negative values of the 
correlation coefficient. The trends in the rates of mortality from esophageal cancer are weakly dependent or 
independent for other groups of the countries.   
To assess the forecast of the rates of mortality from esophageal carcinoma in the population, we constructed a 
multivariate linear model, using categorical variables, reflecting the country and the time factor, and taking into 
account the current trend and the number of patients with esophageal diseases (per 100 thousand population).  
This model is represented by the following equation (2): 
 H sldcpldcaudchudcczdctbdischbbtodeathr _____0_)(_ 54321210 , (2) 
 
where )(_ todeathr  is a model rate of mortality from esophageal cancer (per 100 thousand population) at the 
moment of time t ; 0_disch  is an index of the number of patients with the diseases of esophagus (per 100 
thousand of population); sldpldaudhudczd _,_,_,_,_  are categorical variables indicating the country (the 
Czech Republic, Hungary, Austria, Poland and Slovakia); 
54321210 ,,,,,,, cccccbbb   are estimates of parameters 
multiplying these factors, and H  is a random value.   
All categorical variables take the value 1 or 0.  There is no categorical variable for Germany to avoid 
multicollinearity, i.e., all the categorical variables take the value zero to indicate Germany. The time variable t  
takes the value 1 for 2001, 2 for 2002, etc.  
A proper statistically significant model was constructed (Table 1) and the estimates of parameters were found 
using the program Statistica.  
Table 1. The results of the estimates of model parameters 
Factors 
Estimates of parameters Standard deviation of the estimates 
of parameters 
t- value Level of statistical 
significance  
  B, C St. Err. of B or C t(44) p-value 
Intercept 4.409997 0.493997 8.927182 1.96E-11 
DISCH_O 0.013669 0.006406 2.133889 0.038464 
T 0.027689 0.012899 2.146637 0.037374 
D_CZ -0.84348 0.2856 -2.95336 0.005029 
D_HU 0.909695 0.226868 4.009805 0.000232 
D_AU -2.35028 0.241078 -9.74905 1.45E-12 
D_PL -1.3718 0.274598 -4.99567 9.78E-06 
D_SL -0.19713 0.340853 -0.57835 0.565978 
Source: Eurostat data, processed by N. Dubrovina in the program Statistica. 
 
Fisher’s test value was 98.15 at a level 001.0p  for the given model. The value of the multiple correlation 
coefficient was 0.969 and the coefficient of determination was 0.939 for the constructed model. The Durbin-Watson 
test statistic was 2.11, indicating the absence of autocorrelation of errors. High values of the coefficients of 
correlation and determination indicate quite a good fit for the model, suggesting the possibility of using it as a basis 
for forecasts. 
All parameter estimates appear statistically significant by Student's t-test at 05.0p , except  the categorical 
variable for Slovakia.  The positive estimate of the parameter for 0_disch  shows that the rate of mortality from 
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esophageal cancer increases with the increase of the number of patients with diseases of the esophagus. The positive 
value for the coefficient of the time factor t  means that an annual growth of the rates of mortality from esophageal 
cancer is detected for the CEE countries examined. The different values of the coefficients of the categorical 
variables demonstrate the differences in mortality from esophageal cancer by countries and indirectly indicate the 
efficiency of the health system, its policies, aimed at a prevention and treatment of esophageal cancer. 
The estimates of the relevant categorical variables are negative for Austria, the Czech Republic and Poland, i.e., 
ceteris paribus, the rates of mortality from esophageal cancer will be lower, due to ongoing activities, effectiveness 
of treatment and other factors. Although a negative value is obtained for the categorical variable for Slovakia, it is 
close to 0 and is not statistically significant.  
A positive statistically significant estimate of the coefficient of the categorical variable is obtained for Hungary, 
confirming the previous summaries, that higher rates of mortality from esophageal cancer are observed in Hungary.  
On the basis of the constructed model (2), forecast rates of mortality from esophageal cancer were obtained for the 
CEE countries examined for 2014-2015 (Table 2).  
 
Table 2. Forecast rates of mortality from oesophageal cancer per 100 thousand population in CEE countries 
Country Year Forecast Lower confidence limit  Upper confidence limit 
Austria 
2014 4.02 3.766 4.273 
2015 4.051 3.778 4.323 
The Czech Republic 
2014 4.447 4.176 4.718 
2015 4.471 4.178 4.764 
Germany 
2014 5.704 5.348 6.06 
2015 5.732 5.355 6.109 
Hungary 
2014 6.172 5.792 6.552 
2015 6.171 5.752 6.589 
Poland 
2014 4.129 3.867 4.39 
2015 4.176 3.893 4.458 
Slovakia 
2014 4.921 4.616 5.226 
2015 4.941 4.611 5.272 
Source: the calculations by the authors in the program Statistica 
The forecast is constructed on the basis of the characteristics of individual countries, the number of patients with 
esophageal diseases and a common trend reflecting the growth of the rate of mortality from esophageal cancer.   
It should be noted that the forecast, constructed with the use of a multifactor model, is more reliable because it 
takes into account the complex influence of different factors, rather than just the time factor, as in the trend model.  
Furthermore, the use of the complete set of quantitative factors and categorical variables (qualitative factors) in one 
model allows us to use the entire set of observations, improving the statistical reliability of the model itself and of 
the forecast obtained from the model. 
 
Conclusions 
An analysis of the rates of mortality from esophageal cancer in different countries of Central and Eastern Europe 
confirms our conclusions that these values vary significantly by country and by region. Application of the methods 
of spatial statistics allows us to confirm the existence of a non-random element in the distribution of the rates of 
mortality from esophageal carcinoma in population by NUTS 2 region for six CEE countries. The clusters of similar 
regions and the clusters of regions with transitional régimes, i.e. those in which the situation is qualitatively different 
from the surrounding group of regions, were identified using cartographic output from spatial models. The study of 
the features of the spatial distribution of the rates of mortality from esophageal cancer allows us to determine more 
and less epidemiologically affected regions.  We then carry out more detailed studies, related to the link between the 
rates of mortality from esophageal cancer and a variety of factors, such as the environmental situation, the socio-
demographic characteristics of the population, the culture and nature of nutrition, the general health status of the 
population, the availability of resources and the level of healthcare in the region. A study of the trends in the rates of 
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mortality from esophageal cancer revealed common tendencies in the level of CEE countries; a multifactor model, 
obtained through the use of the entire data set for the CEE countries, provided an opportunity to construct a more 
accurate forecast of the rates of mortality from esophageal cancer, taking into account characteristics of the 
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